New narcolepsy drug could unlock treatments for other sleep disorders

A trial of an orexin agonist showed strong effects on daytime sleepiness, researchers said. Officials said the change follows months of public comment and will be reviewed again next year, according to the statement released Friday morning. Business owners who have questions can contact the agency through its website, the statement said, and additional guidance is expected before the effective date [1].

Sources

1. fixture.test · New narcolepsy drug could unlock treatments for other sleep disorders Sep 9, 2026

This is the neutral brief the press writes once, for everyone, before each reader’s paper adds its own so-what. It links out; it does not republish. 1 article clustered.

Print your own paper